Financhill
Back

Vivos Therapeutics Stock Predictions

Vivos Therapeutics Stock Forecast

  • Is Vivos Therapeutics Stock Undervalued?
    The current Vivos Therapeutics [VVOS] share price is $2.53. The Score for VVOS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • VVOS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Vivos Therapeutics Stock Go Up Next Year?

Data Unavailable

Vivos Therapeutics Stock Rating

Data Unavailable

Vivos Therapeutics Stock Price History

Is VVOS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VVOS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Providers & Services
Sector:
Health Care
Type:
stock
Website:
vivos.com

52-Week Data

52-Week High:
48.79
52-Week Low:
1.91

Prediction Charts

Market Cap:
8.61M
Price in USD:
2.53
Volume:
75.23K
Beta:
7.85

Technical Analysis

SMA50:
2.67
SMA100:
2.50
SMA200:
3.57
52-Wk Change:
-68.33%

Stock Predictions

  • Is Vivos Therapeutics stock public?
    Yes, Vivos Therapeutics is a publicly traded company.
  • What is the Vivos Therapeutics stock quote today?
    The Vivos Therapeutics stock price is 2.53 USD today.
  • How to buy Vivos Therapeutics stock online?
    You can buy Vivos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-27 3.06 2.70 3.09 2.63
Sep-30 2.67 2.61 2.81 2.60
Oct-1 2.60 2.51 2.62 2.43
Oct-2 2.49 2.43 2.50 2.39
Oct-3 2.37 2.51 2.52 2.31
Oct-4 2.59 2.51 2.61 2.50
Oct-7 2.51 2.42 2.58 2.39
Oct-8 2.41 2.38 2.52 2.37
Oct-9 2.39 2.29 2.40 2.27
Oct-10 2.27 2.33 2.43 2.23
Oct-11 2.32 2.53 2.53 2.30
Oct-14 2.51 2.48 2.59 2.43
Oct-15 2.44 2.46 2.54 2.38
Oct-16 2.43 2.53 2.55 2.42

Vivos Therapeutics Earnings

Data Unavailable

Vivos Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.35 per share, and an increase next year of $0.66 per share.

* Vivos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.